35 Non-Tech AI Opportunities Amid DeepSeek Selloff

Page 27 of 35

9. Illumina, Inc. (NASDAQ:ILMN

Number of Hedge Fund Holders: 54 

Illumina, Inc. (NASDAQ:ILMN) offers sequencing and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. The appeal of this company as an investment stems from multiple factors. For instance, as per the report for the third quarter of 2024, GAAP operating margin was 68.6%, and non-GAAP operating margin was 22.6%. This reflects the company’s efficient cost management or high-margin products. Moreover, the company’s non-GAAP operating margin guidance ranges from 21% to 21.5%, demonstrating cost management and operational performance. In addition, the company, along with Regeneron, plans to invest $139.5 million in Truveta to build the largest genetic database. The Truveta Genome Project aims to establish the world’s largest and most diverse database of genetic information.

Page 27 of 35